http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7943138-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6636b59c3149a23a6ae7feaa3984d05f
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4747
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00115
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12
filingDate 2008-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2011-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09f0da42260000eab0f828df105201fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_788d50884e8137e5288f2469ba5ece59
publicationDate 2011-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-7943138-B2
titleOfInvention Survivin peptides as cancer vaccines
abstract Provided are compositions and methods for treating survivin expressing cancers. The compositions contain peptide survivin peptide mimics with improved MHC-I binding characteristics. The method involves administering a survivin peptide mimic with improved MHC-I binding characteristics to an individual to effect inhibition of the growth of survivin expressing cancer cells in the individual.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10293035-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11185578-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10874730-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10434155-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8859488-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11773181-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10167340-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10485858-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10738129-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11160853-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017041092-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11723963-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010008940-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11672847-B2
priorityDate 2007-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007104689-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007083334-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006073159-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004176573-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127548708
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406322
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405859
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5707
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405512
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406323
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4939
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136326756
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129888650
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394880
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID644025
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3821
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104981

Total number of triples: 55.